Literature DB >> 17577478

Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities.

Erik R Dubberke1, Kimberly A Reske, Judith Noble-Wang, Angela Thompson, George Killgore, Jennie Mayfield, Bernard Camins, Keith Woeltje, Jay R McDonald, L Clifford McDonald, Victoria J Fraser.   

Abstract

BACKGROUND: Clostridium difficile spores can contaminate the hospital environment. Little is known about the prevalence and strain variability of C. difficile environmental contamination in health care facilities. The objective of this study was to assess C. difficile environmental contamination at various health care facilities in a metropolitan area and determine if the North American pulsed field gel electrophoresis type 1 (NAP1) strain was present.
METHODS: A cross-sectional pilot survey was conducted. Forty-eight environmental samples were collected from six health care facilities. Samples were cultured for the presence of C. difficile, and positive samples underwent pulsed field gel electrophoresis, toxinotyping, and detection of binary toxin and/or tcdC deletion.
RESULTS: C. difficile was cultured from 13 of 48 (27%) samples. Rooms housing a patient with C. difficile-associated disease (CDAD) were more likely to be culture positive than non-CDAD patient rooms (100% vs. 33%; P < 0.01); C. difficile was not isolated outside of patient rooms (0 of 12 samples). The NAP1 epidemic strain was found in 5 out of 6 facilities.
CONCLUSION: C. difficile spores frequently contaminated the hospital environment. Rooms with a CDAD patient were more likely to be contaminated than rooms without a CDAD patient. The NAP1 strain was prevalent throughout the metropolitan area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577478     DOI: 10.1016/j.ajic.2006.12.006

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  40 in total

1.  Understanding the current state of infection prevention to prevent Clostridium difficile infection: a human factors and systems engineering approach.

Authors:  Eric Yanke; Caroline Zellmer; Sarah Van Hoof; Helene Moriarty; Pascale Carayon; Nasia Safdar
Journal:  Am J Infect Control       Date:  2015-03-01       Impact factor: 2.918

Review 2.  Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Authors:  B Lynn Johnston; Elizabeth Bryce
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

Review 3.  The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment.

Authors:  Roy F Chemaly; Sarah Simmons; Charles Dale; Shashank S Ghantoji; Maria Rodriguez; Julie Gubb; Julie Stachowiak; Mark Stibich
Journal:  Ther Adv Infect Dis       Date:  2014-06

4.  Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.

Authors:  Michelle Merrigan; Anilrudh Venugopal; Michael Mallozzi; Bryan Roxas; V K Viswanathan; Stuart Johnson; Dale N Gerding; Gayatri Vedantam
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

Review 5.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

6.  Detecting Clostridium difficile spores from inanimate surfaces of the hospital environment: which method is best?

Authors:  Tânia Claro; Stephen Daniels; Hilary Humphreys
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

Review 7.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

8.  Improved eradication of Clostridium difficile spores from toilets of hospitalized patients using an accelerated hydrogen peroxide as the cleaning agent.

Authors:  Michelle J Alfa; Evelyn Lo; Alana Wald; Christine Dueck; Pat DeGagne; Godfrey K M Harding
Journal:  BMC Infect Dis       Date:  2010-09-15       Impact factor: 3.090

9.  Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.

Authors:  Anna K Barker; Oguzhan Alagoz; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

10.  Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients.

Authors:  Erik R Dubberke; Anne M Butler; Kimberly A Reske; Denis Agniel; Margaret A Olsen; Gina D'Angelo; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.